Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: A meta-analysis

Gene

Volumn 517, Issue 1, 2013, Pages 65-71

  Hu, Chaoliang ^a   Wang, Jianmiao ^a   Xu, Yuzhu ^a   Li, Xiaochen ^a   Chen, Huilong ^a   Bunjhoo, Hansvin ^a   Xiong, Weining ^a   Xu, Yongjian ^a   Zhao, Jianping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Lung cancer; Matrix metalloproteinases (MMPs); Meta analysis; Polymorphism; Risk

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; STROMELYSIN;

ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG CANCER; META ANALYSIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

CASE-CONTROL STUDIES; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS;

EID: 84873523398     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.12.085     Document Type: Article

References (30)

1. Bayramoglu A., Veysi G.H., Muzaffer M., Irfan D., Azra A., Hulyam K. The association of MMP-9 enzyme activity, MMP-9 C1562T polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 gene expression in lung cancer. Genet. Test. Mol. Biomarkers 2009, 13:671-678.
2. Bayramoglu A., Veysi G.H., Muzaffer M., Irfan D., Azra A., Hulyam K. Is a single nucleotide polymorphism a risk factor for lung cancer in the matrix metalloproteinase-2 promoter?. Mol. Biol. Rep. 2011, 38:1469-1474.
3. Biondi M.L., et al. MMP1 and MMP3 polymorphisms in promoter regions and cancer. Clin. Chem. 2000, 46:2023-2024.
4. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002, 2:161-174.
5. Fakhoury H., Noureddine S., Chmaisse H.N., Tamim H., Makki R.F. MMP1-1607(1G>2G) polymorphism and the risk of lung cancer in Lebanon. Ann. Thorac. Med. 2012, 7:130-132.
6. Fang S., et al. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis 2005, 26:481-486.
7. Ferreras M., Felbor U., Lenhard T., Olsen B.R., Delaisse J.M. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett. 2000, 486:247-251.
8. González-Arriaga P., et al. Polymorphism +17 C/G in matrix metalloprotease MMP8 decreases lung cancer risk. BMC Cancer 2008, 8:378.
9. González-Arriaga P., Pascual T., Garcia-Alvarez A., Fernandez-Somoano A., Lopez-Cima M.F., Tardon A. Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival. BMC Cancer 2012, 12:121.
10. Hart K., Landvik N.E., Lind H., Skaug V., Haugen A., Zienolddiny S. A combination of functional polymorphisms in the CASP8, MMP1, IL10 and SEPS1 genes affects risk of non-small cell lung cancer. Lung Cancer 2011, 71:123-129.
11. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
12. Lei Z., Liu R., Chen J., Zhou Q., Zhang H. Meta analysis of association between polymorphisms in promoter region of MMPs gene and risk of lung cancer. Zhongguo Fei Ai Za Zhi 2009, 12:381-386.
13. Liu D., Duan W., Guo H., Xu X., Bai Y. Meta-analysis of associations between polymorphisms in the promoter regions of matrix met alloproteinases and the risk of colorectal cancer. Int. J. Colorectal Dis. 2011, 26:1099-1105.
14. Liu L., et al. A functional polymorphism (-1607 1G>2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer. Cancer 2011, 117:5172-5181.
15. Price S., Greaves D. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele specific transcriptional regulation. J. Biol. Chem. 2001, 276:7549-7558.
16. Rollin J., et al. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer. Lung Cancer 2007, 56:273-280.
17. Rutter J.L., Mitchell T., Buttice G. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 1998, 58:5321-5325.
18. Schabath M.B., et al. Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. Am. J. Epidemiol. 2005, 161:412-422.
19. Song Association Polymorphisms in the Matrix Metalloproteinase-2 (MMP-2) Gene with Non-small Cell Lung Cancer 2007.
20. Su L., et al. Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 2005, 14:567-570.
21. Su L., et al. Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer. Carcinogenesis 2006, 27:1024-1029.
22. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and bio-chemistry. Circ. Res. 2003, 92:827-839.
23. Wang Y., et al. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma. Lung Cancer 2005, 49:155-161.
24. Word R., Pathi S., Schaffer J. Pathophysiology of pelvic organ prolapse. Obstet. Gynecol. Clin. N. Am. 2009, 36:521-539.
25. Yu C., et al. Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res. 2002, 62:6430-6433.
26. Zhang B., Ye S., Herrmann S., Eriksson P., Henney A. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 1999, 99:1788-1794.
27. Zhang W.Q., Lin H., Zhou Y.A., Wang Y.J., Cheng Q.S. Association of MMP1-1607(1G>2G)single nucleotide polymorphism with susceptibility to lung cancer in Northwestern Chinese population of Han nationality. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2006, 23:313-315.
28. Zhou Y., et al. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility. Carcinogenesis 2005, 26:1117-1121.
29. Zhou P., et al. Current evidence on the relationship between four polymorphisms in the matrix metalloproteinases (MMP) gene and breast cancer risk: a meta-analysis. Breast Cancer Res. Treat. 2011, 127:813-818.
30. Zhu Y., Spitz M.R., Lei L., Mills G.B., Wu X. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res. 2001, 61:7825-7829.